Embolic potential, prevention and management of mural thrombus complicating anterior myocardial infarction: a meta-analysis

Cardiology Unit, Medical Center Hospital of Vermont, University of Vermont, Burlington 05401.

OBJECTIVES. The management of mural thrombus complicating acute anterior myocardial infarction remains controversial in part because of the small size of studies on this topic. We performed a meta-analysis of published studies to address three questions: 1) What is the embolic risk of mural thrombi after myocardial infarction? 2) What is the impact of systemic anticoagulation in reducing the embolic risk of mural thrombi? 3) What is the impact of systemic anticoagulation, thrombolytic therapy and antiplatelet therapy in preventing mural thrombus formation? METHODS. Studies were identified by a computerized and manual search and were included if they were published in manuscript form in the English-language literature. Pooling of data was performed by calculating the Mantel-Haenszel odds ratio and an event rate difference by the method of DerSimonian and Laird. RESULTS. The odds ratio for increased risk of emboli in the presence of echocardiographically demonstrated mural thrombus (11 studies, 856 patients) was 5.45 (95% confidence interval [CI] 3.02 to 9.83), and the event rate difference was 0.09 (95% CI 0.03 to 0.14). The odds ratio of anticoagulation versus no anticoagulation in preventing embolization (seven studies, 270 patients) was 0.14 (95% CI 0.04 to 0.52) with an event rate difference of -0.33 (95% CI -0.50 to -0.16). The odds ratio of anticoagulation versus control in preventing mural thrombus formation (four studies, 307 patients) was 0.32 (95% CI 0.20 to 0.52), and the event rate difference was -0.19 (95% CI -0.09 to -0.28). The odds ratio for thrombolytic therapy in preventing mural thrombus (six studies, 390 patients) was 0.48 (95% CI 0.29 to 0.79) with an event rate difference of -0.16 (95% CI 0.10 to -0.42), whereas for antiplatelet agents (two studies, 112 patients) the odds ratio was 1.43 (95% CI 0.04 to 56.8) with an event rate difference of 0.16 (95% CI -0.20 to 0.52). CONCLUSIONS. This analysis supports the hypotheses that 1) mural thrombus after myocardial infarction poses a significantly increased risk of embolization, 2) the risk of embolization is reduced by systemic anticoagulation, and 3) anticoagulation can prevent mural thrombus formation. Thrombolytic therapy may prevent mural thrombus formation, but evidence for a similar benefit of antiplatelet therapy is lacking.

This article has been cited by other articles:

				A J. Hermosillo and S. A Spinler Aspirin, Clopidogrel, and Warfarin: Is the Combination Appropriate and Effective or Inappropriate and Too Dangerous? Ann. Pharmacother., June 1, 2008; 42(6): 790 - 805. [Abstract] [Full Text] [PDF]

				N U Weir An update on cardioembolic stroke Postgrad. Med. J., March 1, 2008; 84(989): 133 - 142. [Abstract] [Full Text] [PDF]

				D. J. Schneider and B. E. Sobel Conundrums in the Combined Use of Anticoagulants and Antiplatelet Drugs Circulation, July 17, 2007; 116(3): 305 - 315. [Full Text] [PDF]

				A. K. Attili, L. Espinosa, and R. Gebker AJR Teaching File: Left Ventricular Mass in a Patient with Ischemic Heart Disease Am. J. Roentgenol., June 1, 2007; 188(6_Supplement): S31 - S34. [Full Text] [PDF]

				R. T. Meenan, S. Saha, R. Chou, K. Swarztrauber, K. Pyle Krages, M. C. O'Keeffe-Rosetti, M. McDonagh, B. K. S. Chan, M. C. Hornbrook, and M. Helfand Cost-Effectiveness of Echocardiography to Identify Intracardiac Thrombus among Patients with First Stroke or Transient Ischemic Attack Med Decis Making, March 1, 2007; 27(2): 161 - 177. [Abstract] [PDF]

				E. Van De Graaff, M. Dutta, P. Das, E. A. Shry, P. D. Frederick, M. Blaney, D. J. Pasta, and S. R. Steinhubl Early Coronary Revascularization Diminishes the Risk of Ischemic Stroke With Acute Myocardial Infarction Stroke, October 1, 2006; 37(10): 2546 - 2551. [Abstract] [Full Text] [PDF]

				J. I. Suarez Acute Myocardial Infarction, Ischemic Stroke, Sympathetic Stress, and Inflammation: Birds of a Feather Stroke, October 1, 2006; 37(10): 2449 - 2450. [Full Text] [PDF]

				A. Nair, B. Sealove, J. L. Halperin, G. Webber, and V. Fuster Anticoagulation in patients with heart failure: who, when, and why? Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E32 - E38. [Abstract] [Full Text] [PDF]

				T. G. Phan, V. Srikanth, D. C. Reutens, T. T. de Abreu, S. Mateus, J. Correia, and M. J. Alberts Therapeutic Implications for Routine Transthoracic Echocardiography in Acute Ischemic Stroke Patients Stroke, January 1, 2006; 37(1): 11 - 12. [Full Text] [PDF]

				K. Buresly, M. J. Eisenberg, X. Zhang, and L. Pilote Bleeding Complications Associated With Combinations of Aspirin, Thienopyridine Derivatives, and Warfarin in Elderly Patients Following Acute Myocardial Infarction Arch Intern Med, April 11, 2005; 165(7): 784 - 789. [Abstract] [Full Text] [PDF]

				F. O'Rourke, N. Dean, N. Akhtar, and A. Shuaib Current and future concepts in stroke prevention Can. Med. Assoc. J., March 30, 2004; 170(7): 1123 - 1133. [Abstract] [Full Text] [PDF]

				N. R. Mollet, S. Dymarkowski, W. Volders, J. Wathiong, L. Herbots, F. E. Rademakers, and J. Bogaert Visualization of Ventricular Thrombi With Contrast-Enhanced Magnetic Resonance Imaging in Patients With Ischemic Heart Disease Circulation, December 3, 2002; 106(23): 2873 - 2876. [Abstract] [Full Text] [PDF]

				Z. G. Nadareishvili, Z. Choudary, C. Joyner, D. Brodie, and J. W. Norris Cerebral Microembolism in Acute Myocardial Infarction Stroke, December 1, 1999; 30(12): 2679 - 2682. [Abstract] [Full Text] [PDF]

				K.M. Channon and A.P. Banning Echocardiography in stroke and thromboembolism: transoesophageal imaging for all? QJM, November 1, 1999; 92(11): 619 - 621. [Full Text] [PDF]

				M. K. Kapral and F. L. Silver Preventive health care, 1999 update: 2. Echocardiography for the detection of a cardiac source of embolus in patients with stroke Can. Med. Assoc. J., October 1, 1999; 161(8): 989 - 996. [Abstract] [Full Text] [PDF]

				T. Mooe, B.-O. Olofsson, B. Stegmayr, and P. Eriksson Ischemic Stroke : Impact of a Recent Myocardial Infarction Stroke, May 1, 1999; 30(5): 997 - 1001. [Abstract] [Full Text] [PDF]

				K. Tobin, R. Stomel, D. Harber, D. Karavite, J. Sievers, and K. Eagle Validation in a Community Hospital Setting of a Clinical Rule to Predict Preserved Left Ventricular Ejection Fraction in Patients After Myocardial Infarction Arch Intern Med, February 22, 1999; 159(4): 353 - 357. [Abstract] [Full Text] [PDF]

				E. Loh, M. St. J. Sutton, C.-C. C. Wun, J. L. Rouleau, G. C. Flaker, S. S. Gottlieb, G. A. Lamas, L. A. Moye, S. Z. Goldhaber, and M. A. Pfeffer Ventricular Dysfunction and the Risk of Stroke after Myocardial Infarction N. Engl. J. Med., January 23, 1997; 336(4): 251 - 257. [Abstract] [Full Text] [PDF]